Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yann Guillevic"'
Autor:
Francesco Cerisoli, Farzad Ali, Tamás Bereczky, Natacha Bolaños, Lars Bullinger, Sujith Dhanasiri, James Gallagher, Sonia García Pérez, Jan Geissler, Yann Guillevic, Kathryn Harrison, Anastasia Naoum, Carla Portulano, Ana E. Rodríguez Vicente, Renate Schulze-Rath, Gabriela Yumi Gómez, Guillermo Sanz, Jesús María Hernández Rivas
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Value in Health
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Value in Health
OBJECTIVES: The Innovative Medicines Initiative-funded, multistakeholders project Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in hematologY (HARMONY) created a task force involving patient organizations, medical associati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e92fe9270fefc7a49f6fbebef635948a
https://doi.org/10.1016/j.jval.2022.04.1729
https://doi.org/10.1016/j.jval.2022.04.1729
Autor:
Katharina M Lang, Tamás Bereczky, Jan Geissler, Natacha Bolanos, Kathryn E. Morgan, Ananda Plate, Ana Vallejo, Sophie Wintrich, Nick York, Peter Loffelhardt, Brian Huntly, Pieter Sonneveld, Mario Boccadoro, Valeria Santini, Šárka Pospíšilová, Andreas Hochhaus, Tiziano Barbui, Peter Borchmann, Christian Buske, Yann Guillevic, Frederico Calado, Katy Harrison, Dalia Dawoud, Guillermo Sanz, Jesús María Hernández, Ellen De Waal, Martje Barbus, Renate Schulze-Rath, Lars Bullinger
Publikováno v:
Blood. 140:5285-5287
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::579bedf7830ed534db6b57af73704c1e
https://doi.org/10.1182/blood-2022-157549
https://doi.org/10.1182/blood-2022-157549
Autor:
Jesús María Hernández-Rivas, Gilles Salles, Martin Dreyling, Nick York, Gert J. Ossenkoppele, Jesús F. San-Miguel, Pieter Sonneveld, Ananda Plate, Guillermo Sanz, Francesc Bosch, Katy Harrison, Paula R Williamson, Jan Geissler, Hartmut Döhner, Martje Barbus, Valeria Santini, Sophie Wintrich, Natacha Bolanos, Pierre Fenaux, Ana Vallejo, Šárka Pospíšilová, Katharina Lang, Andrea Kündgen, Ellen P.B. de Waal, F Calado, Mario Boccadoro, Tamás Bereczky, Lars Bullinger, Brian J. P. Huntly, Paolo Ghia, Kathryn E. Morgan, Silvia Montoto, Renate Schulze-Rath, Yann Guillevic
Publikováno v:
Blood
Introduction: Commonly accepted standardized sets of outcomes to be measured in clinical trials are still limited. In accordance, outcome measures vary widely between clinical trials even within defined hematological malignancy (HM) entities. Definit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1d8a0e00d631e95519c4561bdf8ba26
Autor:
Ivano Rondelli, Philippe Dostert, Antoine Tarral, Daniele Guastalla, Alessandro Piero Monici Preti, Marie-Claude Homery, Valentina Cenacchi, Maurizio Civelli, Yann Guillevic
Publikováno v:
British Journal of Clinical Pharmacology. 64:304-316
What is already known about this subject • CHF 4227 is a selective oestrogen receptor modulator (SERM) that compares favourably in efficacy and potency with raloxifene in preventing bone loss and lowering serum cholesterol concentrations in OVX rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613c880e691e2dcc23da835a664f4a10
https://doi.org/10.1111/j.1365-2125.2007.02870.x
https://doi.org/10.1111/j.1365-2125.2007.02870.x